Host-Response Diagnostics

Delivering precision medicine on demand


TEDx Palo Alto:
The power of reading the immune system to better diagnose disease

Dr. Tim Sweeney, Inflammatix Co-Founder and CEO

Our tests are addressing significant clinical needs in acute infection and sepsis diagnosis that affect millions of people


In the News: Game Changing Impact

Recent notable news stories

March 9, 2020

Inflammatix named to Fierce 15 MedTech list

Link to story

January 10, 2020

New Technologies Can Step Up Fight Against Antimicrobial Resistance and Sepsis

Link to story

January 10, 2020

Inflammatix raises $32M, plus a BARDA contract, for its point-of-care infection diagnostics

Link to story

December 4, 2019

Genetic platform takes the guesswork out of catching infections

Link to story

Also covered by


Stay in touch with Twitter updates: Find out the latest news.

Connect with Twitter